SUPERSTRING CAPITAL MANAGEMENT LP Quant / Systematic

CIK: 0001931118 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $79,329 (100.0% shares, 0.0% debt)

Holdings (39)

CYTK CYTOKINETICS INC 12.8%
Value ($000) $10,166 Shares 187,633 Est. Cost $51.15 Unrealized +18.0%
LEGN LEGEND BIOTECH CORP 8.6%
Value ($000) $6,850 Shares 154,665 Est. Cost $44.29 Unrealized
TERN TERNS PHARMACEUTICALS INC 8.2%
Value ($000) $6,514 Shares 956,542 Est. Cost $6.06 Unrealized 0.0%
BBIO BRIDGEBIO PHARMA INC 7.0%
Value ($000) $5,568 Shares 219,837 Est. Cost $31.69 Unrealized -13.7%
89BIO INC 6.9%
Value ($000) $5,450 Shares 680,403 Est. Cost $11.17 Unrealized
NKTX NKARTA INC 6.5%
Value ($000) $5,177 Shares 875,999 Est. Cost $8.12 Unrealized -12.8%
ZLAB ZAI LAB LTD 4.7%
Value ($000) $3,729 Shares 215,178 Est. Cost $17.33 Unrealized
KROS KEROS THERAPEUTICS INC 4.3%
Value ($000) $3,395 Shares 74,288 Est. Cost $43.54 Unrealized +23.4%
ACLX ARCELLX INC 4.1%
Value ($000) $3,264 Shares 59,133 Est. Cost $54.36 Unrealized 0.0%
ARWR ARROWHEAD PHARMACEUTICALS IN 3.6%
Value ($000) $2,888 Shares 111,133 Est. Cost $24.57 Unrealized 0.0%
CRBP CORBUS PHARMACEUTICALS HLDGS 3.2%
Value ($000) $2,555 Shares 56,468 Est. Cost $42.06 Unrealized 0.0%
ONC BEIGENE LTD 2.2%
Value ($000) $1,785 Shares 12,508 Est. Cost $142.67 Unrealized
FATE FATE THERAPEUTICS INC 2.1%
Value ($000) $1,631 Shares 497,360 Est. Cost $2.66 Unrealized +64.4%
ALLO ALLOGENE THERAPEUTICS INC 2.0%
Value ($000) $1,607 Shares 689,912 Est. Cost $3.44 Unrealized -14.3%
PYXS PYXIS ONCOLOGY INC 2.0%
Value ($000) $1,604 Shares 484,443 Est. Cost $4.21 Unrealized -0.0%
APGE APOGEE THERAPEUTICS INC 1.8%
Value ($000) $1,453 Shares 36,928 Est. Cost $43.66 Unrealized +11.2%
CTMX CYTOMX THERAPEUTICS INC 1.8%
Value ($000) $1,405 Shares 1,151,518 Est. Cost $1.91 Unrealized +4.5%
NAMS NEWAMSTERDAM PHARMA COMPANY 1.6%
Value ($000) $1,234 Shares 64,213 Est. Cost $20.06 Unrealized 0.0%
TOURMALINE BIO INC 1.5%
Value ($000) $1,225 Shares 95,229 Est. Cost $20.24 Unrealized
NVCR NOVOCURE LTD 1.4%
Value ($000) $1,146 Shares 66,892 Est. Cost $17.59 Unrealized 0.0%
SYRE SPYRE THERAPEUTICS INC 1.4%
Value ($000) $1,071 Shares 45,571 Est. Cost $33.73 Unrealized 0.0%
CABA CABALETTA BIO INC 1.3%
Value ($000) $1,046 Shares 139,895 Est. Cost $21.46 Unrealized -42.9%
TNGX TANGO THERAPEUTICS INC 1.2%
Value ($000) $992 Shares 115,571 Est. Cost $7.73 Unrealized 0.0%
ALLAKOS INC 1.2%
Value ($000) $941 Shares 940,578 Est. Cost $1.26 Unrealized
CATX PERSPECTIVE THERAPEUTICS INC 1.1%
Value ($000) $874 Shares 87,638 Est. Cost $14.46 Unrealized 0.0%
SVRA SAVARA INC 1.0%
Value ($000) $806 Shares 200,000 Est. Cost $4.44 Unrealized +0.3%
BMEA BIOMEA FUSION INC 0.9%
Value ($000) $752 Shares 167,110 Est. Cost $10.16 Unrealized 0.0%
KURA KURA ONCOLOGY INC 0.9%
Value ($000) $746 Shares 36,242 Est. Cost $20.56 Unrealized 0.0%
ZURA ZURA BIO LTD 0.7%
Value ($000) $548 Shares 156,626 Est. Cost $4.08 Unrealized 0.0%
ATYR ATYR PHARMA INC 0.6%
Value ($000) $488 Shares 313,028 Est. Cost $1.74 Unrealized 0.0%
PEPG PEPGEN INC 0.6%
Value ($000) $467 Shares 29,249 Est. Cost $11.81 Unrealized +21.4%
KARYOPHARM THERAPEUTICS INC 0.6%
Value ($000) $464 Shares 534,485 Est. Cost $0.87 Unrealized
EYPT EYEPOINT PHARMACEUTICALS INC 0.4%
Value ($000) $329 Shares 37,838 Est. Cost $13.97 Unrealized 0.0%
MARINUS PHARMACEUTICALS INC 0.4%
Value ($000) $306 Shares 261,861 Est. Cost $10.54 Unrealized
MERSANA THERAPEUTICS INC 0.3%
Value ($000) $221 Shares 110,073 Est. Cost $2.01 Unrealized
LAKESHORE BIOPHARMA CO LTD 0.3%
Value ($000) $200 Shares 307,920 Est. Cost $0.54 Unrealized
CMPS COMPASS PATHWAYS PLC 0.2%
Value ($000) $196 Shares 32,497 Est. Cost $6.04 Unrealized
SYRS SYROS PHARMACEUTICALS INC 0.2%
Value ($000) $195 Shares 37,789 Est. Cost $5.25 Unrealized 0.0%
SPRUCE BIOSCIENCES INC 0.1%
Value ($000) $40 Shares 77,992 Est. Cost $1.36 Unrealized